Get the (ADLS) Report Here
Trade with Jim Cramer 14 Days FREE
Hollis-Eden founder and CEO Richard Hollis was fired 'for cause' by his board, triggering a clause in his contract that strips him of millions of dollars in severance payments.
The company won a favorable ruling in its patent case against Boston Scientific.
Advanced Life Sciences completed antibiotic cethromycin's filing with U.S. regulators and signed an Asian marketing deal with Wyeth.
Amcol falls on an earnings miss.
Cell Therapeutics climbs on positive preliminary study results.
Medarex refuses to face reality about the trial failure of its skin cancer drug.
Micro-cap Advanced Life Sciences faces a tough road.
Advanced Life climbs on study results.
Xoma climbs on a licensing deal with Pfizer.
Local.com soars on a patent award.
Corcept Therapeutics climbs on positive study data.
Health care stocks edge up, helped by successful drug studies and stock offerings.
Advance Life Sciences and Sanofi-Aventis await the FDA's decision on Ketek.
GTC Biotherapeutics is dropping 17%.
©1996-2017 TheStreet, Inc. All rights reserved.Action Alerts PLUS is a registered trademark of TheStreet, Inc.